Ligand Pharma (LGND)
NASDAQ:LGND
Holding LGND?
Track your performance easily

Ligand Pharma (LGND) Technical Analysis

791 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Ligand Pharma’s (LGND) Moving Averages Convergence Divergence (MACD) indicator is 0.69, suggesting Ligand Pharma is a Buy.
Ligand Pharma’s (LGND) 20-Day exponential moving average is 103.34, while Ligand Pharma’s (LGND) share price is $105.01, making it a Buy.
Ligand Pharma’s (LGND) 50-Day exponential moving average is 100.14, while Ligand Pharma’s (LGND) share price is $105.01, making it a Buy.

Ligand Pharma (LGND) Pivot Points

Sep 20, 2024, 01:11 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
101.10
102.56
103.41
104.86
105.72
107.17
108.02
Fibonacci
102.56
103.44
103.98
104.86
105.74
106.29
107.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ligand Pharma (LGND) Moving Averages

Sep 20, 2024, 01:11 PM
Period
Simple
Exponential
MA5
103.96Sell
103.88Sell
MA10
103.22Buy
103.67Buy
MA20
103.95Sell
103.34Buy
MA50
102.50Buy
100.14Buy
MA100
92.08Buy
93.66Buy
MA200
82.39Buy
83.31Buy
Ligand Pharma’s (LGND) 10-Day exponential moving average is 103.67, while Ligand Pharma’s (LGND) share price is $105.01, making it a Buy.
Ligand Pharma’s (LGND) 100-Day exponential moving average is 93.66, while Ligand Pharma’s (LGND) share price is $105.01, making it a Buy.
Ligand Pharma’s (LGND) stock price is $105.01 and Ligand Pharma’s (LGND) 50-day simple moving average is 102.50, creating a Buy signal.
Ligand Pharma’s (LGND) stock price is $105.01 and Ligand Pharma’s (LGND) 100-day simple moving average is 92.08, creating a Buy signal.
Ligand Pharma’s (LGND) stock price is $105.01 and Ligand Pharma’s (LGND) 200-day simple moving average is 82.39, creating a Buy signal.

Ligand Pharma (LGND) Technical Indicators

Sep 20, 2024, 01:11 PM
Name
Value
Implied Action
RSI (14)
52.30
Neutral
STOCH (9,6)
69.31
Neutral
STOCHRSI (14)
54.57
Neutral
MACD (12,26)
0.69
Buy
ADX (14)
12.64
Buy
Williams %R
-51.81
Buy
CCI (14)
11.28
Neutral
ATR (14)
3.35
-
Ultimate Oscillator
41.06
Neutral
ROC
-2.68
Sell
Ligand Pharma’s (LGND) Relative Strength Index (RSI) is 52.30, creating a Neutral signal.
Ligand Pharma’s (LGND) Trend Strength Indicator (ADX) is 12.64, creating a Buy signal.
Ligand Pharma’s (LGND) Commodity Channel Index (CCI) is 11.28, creating a Neutral signal.
Ligand Pharma’s (LGND) Price Rate of Change (ROC) is -2.68, creating a Sell signal.

FAQ

Is LGND a Buy, Hold, or Sell?
Based on LGND’s technical indicators, LGND is a Buy.
    What is LGND’s RSI (14)?
    LGND’s RSI (14) is 52.30, which suggests LGND is a Neutral.
      What is LGND’s MACD?
      LGND’s MACD is 0.69, which suggests LGND is a Buy.
        What is LGND’s 5-day moving average?
        LGND’s 5-day moving average is 103.96, which suggests LGND is a Sell.
          What is LGND’s 20-day moving average?
          LGND 20-day moving average is 103.95, which suggests LGND is a Sell.
            What is LGND’s 50-day moving average?
            LGND’s 50-day moving average is 102.50, which suggests LGND is a Buy.
              What is LGND’s 200-day moving average?
              LGND’s 200-day moving average is 82.39, which suggests LGND is a Buy.
                What is LGND’s Williams % R (14)?
                LGND’s Williams % R (14) is -51.81, which suggests LGND is a Buy.
                  What is LGND’s CCI (14)?
                  LGND’s CCI (14) is 11.28, which suggests LGND is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis